Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders by Wai, HA, Svobodova, E, Herrera, NR, Douglas, AGL, Holloway, JW, Baralle, FE, Baralle, M, Baralle, D